Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab

@article{Richez2009MyeloidDC,
  title={Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab},
  author={Christophe Richez and Thierry Schaeverbeke and Chantal Dumoulin and Jo{\"e}l Dehais and J. F. Moreau and P. F. Blanco},
  journal={Arthritis Research & Therapy},
  year={2009},
  volume={11},
  pages={R100 - R100}
}
INTRODUCTION The objective of our study was to identify the significance of the subtypes of dendritic cell (DC), specifically myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), in rheumatoid arthritis (RA) pathogenesis through their longitudinal follow-up in patients receiving infliximab. METHODS Circulating mDC and pDC levels were evaluated by flow… CONTINUE READING